Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia; [Tratamiento con anticuerpos anti-receptor de IL-6 para COVID-19 grave y la posible implicación de polimorfismos del gen IL-6 en la nueva neumonía por coronavirus]

Zulvikar Syambani Ulhaq; Gita Vita Soraya

doi:10.1016/j.medcli.2020.07.002

← Back to search

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia; [Tratamiento con anticuerpos anti-receptor de IL-6 para COVID-19 grave y la posible implicación de polimorfismos del gen IL-6 en la nueva neumonía por coronavirus]

Open

Zulvikar Syambani Ulhaq, Gita Vita Soraya

2020 Medicina Clinica Vol. 155 Issue 12 Article Cited by 55 SDG 3

Abstract

[No abstract available]

Affiliations

Department of Biochemistry, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University of Malang, Batu, East Java, 65151, Indonesia; Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, 90245, Indonesia

View full text (DOI) →

Research at a Glance

Research at a Glance

Topics & SDG Alignment

Collaboration

Author Profile (Selected)

References Overview

Journal & Source

Metadata & Integrity